Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

GREVE WELLNESS ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6%   Bankruptcy risk   11.4% 13.3% 12.3% 11.4% 23.3% 23.2% 20.4% 15.9%   Credit score (0-100)   23 18 20 21 3 3 4 12   Credit rating   BB BB BB BB B B B BB   Credit limit (kDKK)   -0.0 0.0 -0.0 -0.0 0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -75.1 27.2 57.4 -24.8 -159 -25.8 0.0 0.0   EBITDA   -76.3 -33.2 -119 -93.9 43.9 -56.1 0.0 0.0   EBIT   -80.4 -34.2 -119 -108 33.4 -56.1 0.0 0.0   Pre-tax profit (PTP)   -134.4 -92.4 -123.1 -121.2 17.2 -56.4 0.0 0.0   Net earnings   -102.5 -72.1 -96.0 -94.5 -13.0 -66.2 0.0 0.0   Pre-tax profit without non-rec. items   -134 -92.4 -123 -121 17.2 -56.4 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Tangible assets total   1.0 0.0 70.3 56.2 0.0 0.0 0.0 0.0   Shareholders equity total   -1,355 35.6 -60.4 -155 8.9 -57.3 -182 -182   Interest-bearing liabilities   1,426 41.8 187 402 0.2 18.5 182 182   Balance sheet total (assets)   105 124 188 332 65.0 6.4 0.0 0.0   Net Debt   1,418 28.9 170 300 -48.3 16.7 182 182     See the entire balance sheet 1000.0 Volume  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -75.1 27.2 57.4 -24.8 -159 -25.8 0.0 0.0   Gross profit growth   66.9% 0.0% 110.7% 0.0% -541.5% 83.8% 0.0% 0.0%   Employees   0 1 1 1 1 1 0 0   Employee growth %   -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   105 124 188 332 65 6 0 0   Balance sheet change%   -0.6% 17.7% 51.7% 76.6% -80.4% -90.2% -100.0% 0.0%   Added value   -80.4 -34.2 -118.5 -108.0 33.4 -56.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -8 -2 70 -28 -67 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 -3.0 -4.0 -5.0 1.0 -1.0 0.0 0.0   1000.0 Profitability  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   107.1% -125.5% -206.5% 435.9% -21.0% 217.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -5.7% -4.3% -63.7% -29.4% 12.1% -87.2% 0.0% 0.0%   ROI %   -8.0% -4.6% -89.7% -36.7% 16.2% -407.1% 0.0% 0.0%   ROE %   -97.0% -102.3% -85.9% -36.4% -7.6% -865.8% 0.0% 0.0%   1000.0 Solidity  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Equity ratio %   -92.8% 28.7% -24.3% -32.7% 13.7% -90.0% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -1,858.7% -87.2% -143.4% -320.0% -110.0% -29.9% 0.0% 0.0%   Gearing %   -105.2% 117.5% -309.2% -259.3% 2.2% -32.2% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.4% 7.9% 4.0% 4.5% 8.0% 3.7% 0.0% 0.0%   1000.0 Liquidity  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Quick Ratio   0.1 1.4 0.5 0.6 1.2 0.1 0.0 0.0   Current Ratio   0.1 1.4 0.5 0.6 1.2 0.1 0.0 0.0   Cash and cash equivalent   7.2 12.9 16.9 101.3 48.5 1.7 0.0 0.0   1000.0 Capital use efficiency  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,355.7 35.6 -130.7 -211.2 8.9 -57.3 -91.1 -91.1   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 -34 -119 -108 33 -56 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 -33 -119 -94 44 -56 0 0   EBIT / employee   0 -34 -119 -108 33 -56 0 0   Net earnings / employee   0 -72 -96 -95 -13 -66 0 0